Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026

GlobeNewswire08-04

GARDEN CITY, N.Y., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 a.m. Eastern Time (ET) the same day.

Conference Call & Webcast
*Thursday, August 13th @ 8 a.m. ET*
Domestic:	1-877-407-0784
International:	1-201-689-8560
Conference ID:	13762077

Webcast: A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call.

About Beyond Air, Inc.
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net.

CONTACTS:

Corey Davis, Ph.D.
LifeSci Advisors, LLC
Cdavis@lifesciadvisors.com
(212) 915-2577

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2656556465?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-04 20:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2656556465","market":"us","top_or_hot":-1,"title":"Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026","media":"GlobeNewswire","content":"<html><body><p>GARDEN CITY, N.Y., Aug.  04, 2026  (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/XAIR\">Beyond Air</a>, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 a.m. Eastern Time (ET) the same day.</p> <table><tr><td><strong>Conference Call &amp; Webcast</strong></td><td> </td></tr><tr><td><strong><em><u>Thursday, August 13th @ 8 a.m. ET</u></em></strong></td><td> </td></tr><tr><td><strong>Domestic:</strong>  </td><td>1-877-407-0784</td></tr><tr><td><strong>International:</strong> </td><td>1-201-689-8560</td></tr><tr><td><strong>Conference ID:</strong></td><td>13762077</td></tr></table> <p><strong>Webcast: </strong>A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call.</p> <p><strong>About Beyond Air, Inc.</strong><br/>Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net.</p> <p><strong>CONTACTS:</strong></p> <p>Corey Davis, Ph.D.<br/>LifeSci Advisors, LLC<br/><u>Cdavis@lifesciadvisors.com</u> <br/>(212) 915-2577</p> <br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/YzJmNGI1MzItZjQ0Zi00Mjk3LWIzZTktY2E0Nzk2MzczYzhjLTEwOTU0OTktMjAyNi0wOC0wNC1lbg==/tiny/Beyond-Air-.png\"/></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1016364462\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">GlobeNewswire </p>\n<p class=\"h-time\">2026-08-04 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>GARDEN CITY, N.Y., Aug.  04, 2026  (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/XAIR\">Beyond Air</a>, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 a.m. Eastern Time (ET) the same day.</p> <table><tr><td><strong>Conference Call &amp; Webcast</strong></td><td> </td></tr><tr><td><strong><em><u>Thursday, August 13th @ 8 a.m. ET</u></em></strong></td><td> </td></tr><tr><td><strong>Domestic:</strong>  </td><td>1-877-407-0784</td></tr><tr><td><strong>International:</strong> </td><td>1-201-689-8560</td></tr><tr><td><strong>Conference ID:</strong></td><td>13762077</td></tr></table> <p><strong>Webcast: </strong>A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call.</p> <p><strong>About Beyond Air, Inc.</strong><br/>Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net.</p> <p><strong>CONTACTS:</strong></p> <p>Corey Davis, Ph.D.<br/>LifeSci Advisors, LLC<br/><u>Cdavis@lifesciadvisors.com</u> <br/>(212) 915-2577</p> <br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/YzJmNGI1MzItZjQ0Zi00Mjk3LWIzZTktY2E0Nzk2MzczYzhjLTEwOTU0OTktMjAyNi0wOC0wNC1lbg==/tiny/Beyond-Air-.png\"/></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EIPX","symbol_name":"FT ENERGY INCOME PARTNERS STRATEGY ETF","start_time":0,"source_url":"https://www.globenewswire.com/news-release/2026/08/04/3338217/0/en/Beyond-Air-Schedules-Conference-Call-to-Discuss-Financial-Results-for-the-Quarter-Ended-June-30-2026.html","article_id":"2656556465","we_media_id":"1016364462","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2656556465","pubTimestamp":1785844800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"GlobeNewswire","introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"summary":"GARDEN CITY, N.Y., Aug.  04, 2026  (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harne","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EIPX":"FT ENERGY INCOME PARTNERS STRATEGY ETF","TPZ":"Tortoise Electrification Infrastructure ETF","ET":"Energy Transfer LP","BK4561":"索罗斯持仓","BK4082":"医疗保健设备","BK4581":"高盛持仓","MDST":"Westwood Salient Enhanced Midstream Income ETF","BK4144":"石油与天然气的储存和运输","MLPA":"Global X MLP ETF","UMI":"USCF Midstream Energy Income Fund","BK4590":"PTP","BK4585":"ETF&股票定投概念","ENFR":"Alerian Energy Infrastructure ET","EMLP":"第一信托北美能源基础设施基金","XAIR":"BEYOND AIR INC","AMLP":"Alerian MLP ETF","TNGY":"Tortoise Energy Fund","AMZA":"InfraCap MLP ETF","USAI":"Pacer American Energy Independence ETF","EIPI":"FT Energy Income Partners Enhanced Income Etf","BK4588":"碎股"},"translate_title":"Beyond Air 安排电话会议讨论截至 2026 年 6 月 30 日的季度财务业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EIPX":0.6,"USAI":0.6,"EIPI":0.6,"AMLP":0.6,"MDST":0.6,"AMZA":0.6,"MLPA":0.6,"EMLP":0.6,"TPZ":0.6,"UMI":0.6,"ET":1,"XAIR":1,"ENFR":0.6,"TNGY":0.6},"content_text":"GARDEN CITY, N.Y., Aug.  04, 2026  (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 a.m. Eastern Time (ET) the same day. Conference Call & Webcast Thursday, August 13th @ 8 a.m. ET Domestic:  1-877-407-0784International: 1-201-689-8560Conference ID:13762077 Webcast: A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call. About Beyond Air, Inc.Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net. CONTACTS: Corey Davis, Ph.D.LifeSci Advisors, LLCCdavis@lifesciadvisors.com (212) 915-2577","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2656556465","isCrawlerRequest":true}